These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Singh N; Gayowski T; Wagener M; Yu VL Transplantation; 1994 Oct; 58(7):774-8. PubMed ID: 7524204 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Vilchez R; Shapiro R; McCurry K; Kormos R; Abu-Elmagd K; Fung J; Kusne S Transpl Int; 2003 May; 16(5):336-40. PubMed ID: 12759725 [TBL] [Abstract][Full Text] [Related]
5. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691 [TBL] [Abstract][Full Text] [Related]
7. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091 [TBL] [Abstract][Full Text] [Related]
8. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
9. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients. Corman SL; Coley KC; Schonder KS Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous cryptococcosis mimicking bacterial cellulitis in a liver transplant recipient: case report and review in solid organ transplant recipients. Singh N; Rihs JD; Gayowski T; Yu VL Clin Transplant; 1994 Aug; 8(4):365-8. PubMed ID: 7949540 [TBL] [Abstract][Full Text] [Related]
11. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Husain S; Wagener MM; Singh N Emerg Infect Dis; 2001; 7(3):375-81. PubMed ID: 11384512 [TBL] [Abstract][Full Text] [Related]
12. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients. Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888 [TBL] [Abstract][Full Text] [Related]
13. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Singh N; Gayowski T; Wagener MM Liver Transpl; 2001 Feb; 7(2):100-5. PubMed ID: 11172392 [TBL] [Abstract][Full Text] [Related]
14. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection? Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496 [TBL] [Abstract][Full Text] [Related]
16. Intracranial granuloma and skull osteolysis: complication of a primary cutaneous cryptococcosis in a kidney transplant recipient. Rerolle JP; Szelag JC; Diaconita M; Paraf F; Aldigier JC; Le Meur Y Am J Kidney Dis; 2005 Dec; 46(6):e113-7. PubMed ID: 16310562 [TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565 [TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection. Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086 [TBL] [Abstract][Full Text] [Related]
19. Hepatic involvement in a liver transplant recipient with disseminated cryptococcosis. Lu S; Furth EE; Blumberg EA; Bing Z Transpl Infect Dis; 2009 Apr; 11(2):179-82. PubMed ID: 19210677 [TBL] [Abstract][Full Text] [Related]